Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

DSGN

Design Therapeutics (DSGN)

Design Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DSGN
DateTimeSourceHeadlineSymbolCompany
03/10/20257:30AMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DSGNDesign Therapeutics Inc
03/10/20257:16AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:DSGNDesign Therapeutics Inc
03/10/20257:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DSGNDesign Therapeutics Inc
03/10/20257:07AMGlobeNewswire Inc.Design Therapeutics Highlights Progress Across Lead GeneTAC® Programs and Reports Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:DSGNDesign Therapeutics Inc
03/03/20258:00AMGlobeNewswire Inc.Design Therapeutics to Participate in Leerink’s Global Healthcare ConferenceNASDAQ:DSGNDesign Therapeutics Inc
02/07/20254:16PMEdgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:DSGNDesign Therapeutics Inc
02/07/20254:15PMEdgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:DSGNDesign Therapeutics Inc
01/13/20259:09AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DSGNDesign Therapeutics Inc
01/06/20257:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DSGNDesign Therapeutics Inc
01/06/20257:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DSGNDesign Therapeutics Inc
12/19/20246:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DSGNDesign Therapeutics Inc
11/13/20248:00AMGlobeNewswire Inc.Design Therapeutics to Participate in Multiple Upcoming Investor ConferencesNASDAQ:DSGNDesign Therapeutics Inc
11/07/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DSGNDesign Therapeutics Inc
11/07/20244:01PMGlobeNewswire Inc.Design Therapeutics Announces Third Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTACTM PortfolioNASDAQ:DSGNDesign Therapeutics Inc
09/10/20248:00AMGlobeNewswire Inc.Design Therapeutics to Participate in the 2024 Cantor Global Healthcare ConferenceNASDAQ:DSGNDesign Therapeutics Inc
08/12/20244:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DSGNDesign Therapeutics Inc
08/09/20244:20PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DSGNDesign Therapeutics Inc
08/05/20248:12AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DSGNDesign Therapeutics Inc
08/05/20248:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DSGNDesign Therapeutics Inc
08/05/20248:00AMGlobeNewswire Inc.Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTAC™ PortfolioNASDAQ:DSGNDesign Therapeutics Inc
06/17/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DSGNDesign Therapeutics Inc
06/17/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DSGNDesign Therapeutics Inc
06/17/20244:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DSGNDesign Therapeutics Inc
05/08/20244:31PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DSGNDesign Therapeutics Inc
05/08/20244:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DSGNDesign Therapeutics Inc
05/08/20244:05PMGlobeNewswire Inc.Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program MilestonesNASDAQ:DSGNDesign Therapeutics Inc
05/07/20246:30AMGlobeNewswire Inc.Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:DSGNDesign Therapeutics Inc
03/19/20244:01PMGlobeNewswire Inc.Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:DSGNDesign Therapeutics Inc
03/19/20247:27AMIH Market NewsUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices RetreatNASDAQ:DSGNDesign Therapeutics Inc
03/12/20246:30AMGlobeNewswire Inc.Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio UpdateNASDAQ:DSGNDesign Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:DSGN